Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
L
Lineage Cell Therapeutics Inc
F:BT3
Lineage Cell Therapeutics Inc
F:BT3
Price:
0.831
EUR
-6%
Market Closed
Market Cap:
€156.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lineage Cell Therapeutics Inc
F:BT3
|
US |
|
F
|
Furukawa Electric Co Ltd
SWB:FKA
|
JP |
|
Christina Lake Cannabis Corp
OTC:CLCFF
|
CA |
|
B
|
Bangkok Dec-Con PCL
SET:BKD
|
TH |
Wall St Price Targets
BT3 Price Forecast
Based on 8 analysts
Based on 8 analysts
+405% Upside
from
€0.831
today
Lineage Cell Therapeutics Inc (BT3)’s 12-month stock price forecast through October 2027 has a consensus target of €4.199, implying 405% upside. The forecast is based on price targets from 8 Wall Street analysts.
Lineage Cell Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BT3's stock price target?
Price Target
4.199
EUR
4.199
EUR
According to Wall Street analysts, the average 1-year price target for BT3 is 4.199 EUR with a low forecast of 2.772 EUR and a high forecast of 8.646 EUR.
What is the Revenue forecast for Lineage Cell Therapeutics Inc?
Projected CAGR
74%
74%
Over the last 1 year, the compound annual growth rate for Revenue has been 53%. The projected CAGR for the next 8 years is 74%.
What is the Gross Profit forecast for Lineage Cell Therapeutics Inc?
Projected CAGR
74%
74%
Over the last 1 year, the compound annual growth rate for Gross Profit has been 57%. The projected CAGR for the next 8 years is 74%.